Terns Pharmaceuticals (TERN) Competitors $3.56 +0.26 (+7.88%) Closing price 04:00 PM EasternExtended Trading$3.55 -0.01 (-0.39%) As of 04:20 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock TERN vs. WVE, ETNB, COLL, MLYS, NTLA, SYRE, ZYME, RCUS, NRIX, and CMRXShould you be buying Terns Pharmaceuticals stock or one of its competitors? The main competitors of Terns Pharmaceuticals include Wave Life Sciences (WVE), 89bio (ETNB), Collegium Pharmaceutical (COLL), Mineralys Therapeutics (MLYS), Intellia Therapeutics (NTLA), Spyre Therapeutics (SYRE), Zymeworks (ZYME), Arcus Biosciences (RCUS), Nurix Therapeutics (NRIX), and Chimerix (CMRX). These companies are all part of the "pharmaceutical products" industry. Terns Pharmaceuticals vs. Wave Life Sciences 89bio Collegium Pharmaceutical Mineralys Therapeutics Intellia Therapeutics Spyre Therapeutics Zymeworks Arcus Biosciences Nurix Therapeutics Chimerix Wave Life Sciences (NASDAQ:WVE) and Terns Pharmaceuticals (NASDAQ:TERN) are both small-cap medical companies, but which is the better stock? We will contrast the two companies based on the strength of their institutional ownership, risk, media sentiment, valuation, community ranking, profitability, analyst recommendations, earnings and dividends. Does the media prefer WVE or TERN? In the previous week, Wave Life Sciences had 4 more articles in the media than Terns Pharmaceuticals. MarketBeat recorded 10 mentions for Wave Life Sciences and 6 mentions for Terns Pharmaceuticals. Terns Pharmaceuticals' average media sentiment score of 1.43 beat Wave Life Sciences' score of 1.08 indicating that Terns Pharmaceuticals is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Wave Life Sciences 4 Very Positive mention(s) 1 Positive mention(s) 2 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive Terns Pharmaceuticals 4 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Which has more volatility & risk, WVE or TERN? Wave Life Sciences has a beta of -0.93, meaning that its share price is 193% less volatile than the S&P 500. Comparatively, Terns Pharmaceuticals has a beta of -0.13, meaning that its share price is 113% less volatile than the S&P 500. Which has stronger earnings & valuation, WVE or TERN? Wave Life Sciences has higher revenue and earnings than Terns Pharmaceuticals. Wave Life Sciences is trading at a lower price-to-earnings ratio than Terns Pharmaceuticals, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioWave Life Sciences$108.30M10.94-$57.51M-$0.79-9.77Terns PharmaceuticalsN/AN/A-$90.21M-$1.13-2.92 Do institutionals and insiders hold more shares of WVE or TERN? 89.7% of Wave Life Sciences shares are held by institutional investors. Comparatively, 98.3% of Terns Pharmaceuticals shares are held by institutional investors. 29.1% of Wave Life Sciences shares are held by company insiders. Comparatively, 15.1% of Terns Pharmaceuticals shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term. Does the MarketBeat Community prefer WVE or TERN? Wave Life Sciences received 325 more outperform votes than Terns Pharmaceuticals when rated by MarketBeat users. Likewise, 67.90% of users gave Wave Life Sciences an outperform vote while only 59.72% of users gave Terns Pharmaceuticals an outperform vote. CompanyUnderperformOutperformWave Life SciencesOutperform Votes36867.90% Underperform Votes17432.10% Terns PharmaceuticalsOutperform Votes4359.72% Underperform Votes2940.28% Do analysts rate WVE or TERN? Wave Life Sciences currently has a consensus target price of $21.17, indicating a potential upside of 174.18%. Terns Pharmaceuticals has a consensus target price of $18.38, indicating a potential upside of 456.82%. Given Terns Pharmaceuticals' higher probable upside, analysts clearly believe Terns Pharmaceuticals is more favorable than Wave Life Sciences.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Wave Life Sciences 0 Sell rating(s) 1 Hold rating(s) 10 Buy rating(s) 1 Strong Buy rating(s) 3.00Terns Pharmaceuticals 0 Sell rating(s) 2 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 2.60 Is WVE or TERN more profitable? Terns Pharmaceuticals has a net margin of 0.00% compared to Wave Life Sciences' net margin of -66.50%. Terns Pharmaceuticals' return on equity of -32.76% beat Wave Life Sciences' return on equity.Company Net Margins Return on Equity Return on Assets Wave Life Sciences-66.50% -280.57% -52.90% Terns Pharmaceuticals N/A -32.76%-31.33% SummaryWave Life Sciences beats Terns Pharmaceuticals on 10 of the 18 factors compared between the two stocks. Get Terns Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for TERN and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart TERN vs. The Competition Export to ExcelMetricTerns PharmaceuticalsPharmaceutical IndustryMedical SectorNASDAQ ExchangeMarket Cap$288.08M$6.89B$5.56B$7.83BDividend YieldN/A3.05%5.11%4.22%P/E Ratio-2.807.4422.4418.48Price / SalesN/A242.70393.95103.59Price / CashN/A65.8538.1834.62Price / Book0.806.516.774.25Net Income-$90.21M$143.21M$3.22B$248.23M7 Day Performance8.20%1.98%1.45%0.89%1 Month Performance28.91%6.89%3.96%3.53%1 Year Performance-35.04%-2.52%16.07%5.08% Terns Pharmaceuticals Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)TERNTerns Pharmaceuticals4.2794 of 5 stars$3.56+7.9%$18.38+416.2%-34.7%$310.78MN/A-3.0240Positive NewsWVEWave Life Sciences4.3154 of 5 stars$6.12+3.4%$22.18+262.4%+56.6%$939.33M$108.30M-5.51240Upcoming EarningsAnalyst ForecastAnalyst RevisionNews CoverageETNB89bio2.9783 of 5 stars$6.27+3.5%$27.56+339.5%-5.8%$915.32MN/A-2.1540Upcoming EarningsAnalyst UpgradeNews CoveragePositive NewsCOLLCollegium Pharmaceutical4.0384 of 5 stars$26.91-0.4%$43.60+62.0%-26.9%$864.67M$631.45M11.60210Upcoming EarningsPositive NewsMLYSMineralys Therapeutics2.3833 of 5 stars$13.24-0.8%$33.00+149.2%+16.0%$858.96MN/A-3.6428Upcoming EarningsShort Interest ↑NTLAIntellia Therapeutics4.5482 of 5 stars$7.92+9.5%$36.68+363.2%-58.6%$819.86M$57.88M-1.46600Upcoming EarningsPositive NewsHigh Trading VolumeSYRESpyre Therapeutics1.9151 of 5 stars$13.57+7.1%$49.57+265.3%-53.9%$817.95M$890,000.00-1.82100Upcoming EarningsNews CoveragePositive NewsZYMEZymeworks2.7638 of 5 stars$11.75+1.9%$21.00+78.7%+51.6%$817.53M$76.30M-7.83460Upcoming EarningsAnalyst RevisionPositive NewsRCUSArcus Biosciences2.2787 of 5 stars$7.68-2.5%$30.25+293.9%-42.6%$807.46M$258M-2.44500Upcoming EarningsPositive NewsNRIXNurix Therapeutics1.9305 of 5 stars$10.55+3.0%$30.44+188.6%-4.1%$804.29M$56.42M-3.65300Analyst ForecastCMRXChimerix3.0064 of 5 stars$8.55-0.1%$8.53-0.1%N/A$801.56M$212,000.00-9.0990 Related Companies and Tools Related Companies Wave Life Sciences Competitors 89bio Competitors Collegium Pharmaceutical Competitors Mineralys Therapeutics Competitors Intellia Therapeutics Competitors Spyre Therapeutics Competitors Zymeworks Competitors Arcus Biosciences Competitors Nurix Therapeutics Competitors Chimerix Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:TERN) was last updated on 5/1/2025 by MarketBeat.com Staff From Our PartnersHow to invest in Elon Musk’s Optimus before its launchElon Musk is set to completely take over the AI industry with Optimus… A breakthrough AI-powered robot that El...InvestorPlace | SponsoredBlackrock’s Sending THIS Crypto Higher on PurposeWhile everyone's distracted by Bitcoin's moves, a stealth revolution is underway. One altcoin is quietly po...Crypto 101 Media | SponsoredElon Set to Shock the World by May 1st ?Tech legend Jeff Brown recently traveled to the industrial zone of South Memphis to investigate what he believ...Brownstone Research | SponsoredElon Musk’s next move from the Oval Office?No one is closer to President Trump than Tesla CEO Elon Musk. He's been dubbed Trump's "first buddy." Tr...Weiss Ratings | SponsoredThis Is How Empires FallThe headlines scream tariffs and export bans — but the real damage is happening in retirement portfolios. Tim ...Investors Alley | SponsoredIs he more powerful than Trump? Is there anybody more powerful than Donald Trump right now? In a single tariff announcement, he wiped out n...Porter & Company | Sponsored[Action Required] Claim Your FREE IRS Loophole GuideThis shouldn't surprise anyone who's been paying attention, but... Pres. Trump may be about to unleash the ...Colonial Metals | SponsoredTrump and Buffett Are Quietly Leading America’s Gold RevivalThe “Buffett Indicator” Predicts Gold Set To Dominate for Next Decade Each time the Buffett Indicator has...Golden Portfolio | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Terns Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Terns Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy TERN Stock Free TERN Stock Alerts